Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
521 Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. 2006
522 17. Excellent absorption enhancing characteristics of No Donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers. 2006
523 Ca-alginate beads loaded with meloxicam: Effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug. 2006
524 17. Excellent absorption enhancing characteristics of No Donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers. 2006
525 18. Colon-Specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives. 2006
526 Interaction of tiaramide hydrochloride with Amberlite resins: Characterization of the interaction and modulation of the release through microencapsulation of the prepared resinates. 2006
527 Formulation and Evaluation of Famotidine Sublingual Tablets.


2005
528 Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study. 2005
529 Formulation and Evaluation of Famotidine Sublingual Tablets.


2005
530 Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. 2005